In‐Jin Jang

824 citations
27 papers · 660 indexed · h-index 14
Topics
Pharmacogenetics and Drug Metabolism (8 papers)Pharmacological Effects and Toxicity Studies (4 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)

In The Last Decade

In‐Jin Jang

26 papers receiving 641 citations

Peers

In‐Jin Jang
Comparison fields: 5 of 80
  • Pharmacology 222
  • Oncology 153
  • Pharmacology 146
  • Pediatrics, Perinatology and Child Health 123
  • Molecular Biology 105
Replace Sang‐Goo Shin with:
Sang‐Goo Shin South Korea
Jong‐Lyul Ghim South Korea
Sung Eun Sim South Korea
P.A. Soons Netherlands
Brian W. Ogilvie United States
Manoranjenni Chetty United Kingdom
SoJeong Yi South Korea
Sara Moráis Portugal
Danilo Wegner Germany
Justin D. Lutz United States
In‐Jin Jang relative to Sang‐Goo Shin South Korea Sang‐Goo Shin's profile →
Citations per field
00.5×1.7×
Sang‐Goo Shin · 1×
Citations per year

Countries citing papers authored by In‐Jin Jang

Since Specialization
Citations

This map shows the geographic impact of In‐Jin Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In‐Jin Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In‐Jin Jang more than expected).

Fields of papers citing papers by In‐Jin Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In‐Jin Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In‐Jin Jang. The network helps show where In‐Jin Jang may publish in the future.

Co-authorship network of co-authors of In‐Jin Jang

This figure shows the co-authorship network connecting the top 25 collaborators of In‐Jin Jang. A scholar is included among the top collaborators of In‐Jin Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In‐Jin Jang. In‐Jin Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 11
3 4
4 21
5 4
6 25
7 7
8 9
9 11
10 23
11 37
12 58
13 13
14 58
15 32
16 38
17 4
18 51
19 15
20 107

About In‐Jin Jang

In‐Jin Jang is a scholar working on Pharmacology, Pharmacology and Gastroenterology, having authored 27 papers that have together received 660 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Pharmacology (222 citations), Gastroenterology (54 citations) and Pharmacology (146 citations). In‐Jin Jang has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Kyung‐Sang Yu, Joo‐Youn Cho, Sang‐Goo Shin, SeungHwan Lee, Dong‐Ryul Sohn, Jae‐Gook Shin, Bo‐Hyung Kim, Seo Hyun Yoon, Takashi Ishizaki and Kyoung Soo Lim. Their work appears in journals such as Epilepsia, Clinical Pharmacology & Therapeutics and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026